|
I'm sorry, I'm not interested http://thaiactivity.com/intelmedme-4252.pdf webdrugs.com The drug will carry a Boxed Warning alerting patients and health care professionals that the drug should not be used in pregnant women because it can harm the developing fetus. Women will be able to receive the drug only through the Adempas REMS program, which will require them to comply with pregnancy testing requirements and be counseled regarding the need for contraception.
|